BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UX-GIP001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of UX-GIP001\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07244328-8903@assetmemo.bio
DTSTAMP:20261121T005737Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:UX-GIP001: Phase 1 readout est. (NCT07244328)
DESCRIPTION:UX-GIP001\, phase 1\, Epilepsy.\nStudy: Exploratory Study of UX
 -GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesi
 al Temporal Lobe Epilepsy (MTLE)\nEstimated primary completion: 30 Novembe
 r 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/ux-gip001#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0724432
 8
URL:https://assetmemo.bio/drug/ux-gip001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07572812-8903@assetmemo.bio
DTSTAMP:20261121T005737Z
DTSTART;VALUE=DATE:20290701
DTEND;VALUE=DATE:20290702
SUMMARY:UX-GIP001: Phase 1 readout est. (NCT07572812)
DESCRIPTION:UX-GIP001\, phase 1\, Epilepsy.\nStudy: A Phase I Clinical Tria
 l of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Tempor
 al Lobe Epilepsy\nEstimated primary completion: 1 July 2029. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/ux-gip001#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07572812
URL:https://assetmemo.bio/drug/ux-gip001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
